Sepsis Diagnostics Market

bioMérieux (France) and Becton, Dickinson and Company (US) are the Prominent Players in the Sepsis Diagnostics Market

The global sepsis diagnostics market size is projected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%. The growth of this market is primarily driven by the rising prevalence of sepsis across the globe, the growing geriatric population, the increasing number of surgical procedures, and a high incidence of HAIs that are driving the growth of the sepsis diagnostics market. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.

Some prominent players in the sepsis diagnostics market are bioMérieux (France), Becton, Dickinson and Company (US), Danaher (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland). An analysis of the developments in the sepsis diagnostics industry from 2016–2019 showed that product launches, expansions, agreements, partnerships, collaborations, and acquisitions were the most widely adopted growth strategies in the market.

To know about the assumptions considered for the study download the pdf brochure

bioMérieux (France) held the leadership position in the global sepsis diagnostics market in 2018. The company has been focusing new product development and product approvals in the field of sepsis diagnostics. For instance, in April 2017, bioMérieux received FDA approval for its BacT/ALERT VIRTUO fully automated blood culture system. In July 2016, bioMérieux received FDA approval for the expanded use of its VIDAS B•R•A•H•M•S PCT (Procalcitonin) assay. Through this, it introduced innovative products in the market, which enabled it to garner a higher market share. In addition, the company has a strong global presence with well-connected distribution channels to serve markets in North America, Europe, Oceania, Africa, and Asia Pacific.

Becton, Dickinson and Company (US) held the second position in the global sepsis diagnostics market in 2018. The company has a diversified portfolio, which includes automated blood culture instruments, blood culture medium, blood culture consumables, and laboratory data management software. With the objective of improving the patient’s quality of life, the company is concentrating on developing new products and is focusing its efforts on gaining product approvals. In line with this, in August 2017, BD received FDA approval for its BD BACTEC Standard Aerobic and Standard Anaerobic blood culture bottles in plastic. Likewise, in March 2016, the company received approval for its BD BACTEC PEDS Plus/F blood culture bottles in plastic, which were initially available in glass. The company’s leadership position in the market can be attributed to its strong distribution network in both developed as well as developing countries across the globe, which enables it to serve customers in North America, Europe, Asia Pacific, Eastern Europe, the Middle East, and Africa.

Related Reports:

Sepsis Diagnostics Market by Technology (Microbiology, PCR, Microarray, Immunoassay, Biomarkers), Product (Reagents, Assay, Instruments, Software), Method, Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End User and Region - Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
MD 4575
RI Published ON
5/14/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sepsis Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved